Prevention of cardiovascular morbidity with angiotension receptor blockade: life after LIFE.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D001262:Atenolol / Q000627:therapeutic use; D002985:Clinical Protocols; D048909:Diabetes Complications; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology* / Q000401:mortality; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy; D019808:Losartan / Q000627:therapeutic use*; D009017:Morbidity; D012306:Risk
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000804:Angiotensin II; D001262:Atenolol; D019808:Losartan